_id
6913048cccc777a4e85d7a60
Ticker
IVA
Name
Inventiva Sa
Exchange
NASDAQ
Address
50 rue de Dijon, Daix, France, 21121
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://inventivapharma.com
Description
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.
Last Close
4.49
Volume
175026
Current Price
4.46
Change
-0.6681514476614754
Last Updated
2025-12-01T09:32:47.026Z
Image
data:image/webp;base64,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
Ipo Date
2020-07-10T00:00:00.000Z
Market Cap
557306368
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.84443125
Sentiment Sources
16
Rating
4.7143
Target Price
15.875
Strong Buy
6
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
4454000
Cost Of Revenue
1704000
Gross Profit
2750000
Operating Expenses
59552000
Operating Income
-56802000
Interest Expense
9745000
Pretax Income
-177510000
Net Income
-175882000
Eps
-1.6159737983688223
Dividends Per Share
-
Shares Outstanding
145891723
Income Tax Expense
-1628000
EBITDA
-165841000
Operating Margin
-1275.303098338572
Total Other Income Expense Net
-120708000
Cash
122076000
Short Term Investments
24578000
Receivables
22792000
Inventories
-
Total Current Assets
172374000
Property Plant Equipment
3985000
Total Assets
178518000
Payables
34703000
Short Term Debt
5533000
Long Term Debt
51599000
Total Liabilities
187866000
Equity
-9346000
Depreciation
1704000
Change In Working Capital
-1645000
Cash From Operations
-53893000
Capital Expenditures
57000
Cash From Investing
-24799000
Cash From Financing
104949000
Net Change In Cash
25512000
PE
-
PB
-51.9393084271346
ROE
1881.8959982880376
ROA
-98.52339820074167
FCF
-53950000
Fcf Percent
-12.112707678491244
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
1.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
3
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
4454000
Quarters > 0 > income Statement > cost Of Revenue
1704000
Quarters > 0 > income Statement > gross Profit
2750000
Quarters > 0 > income Statement > operating Expenses
59552000
Quarters > 0 > income Statement > operating Income
-56802000
Quarters > 0 > income Statement > interest Expense
9745000
Quarters > 0 > income Statement > pretax Income
-177510000
Quarters > 0 > income Statement > net Income
-175882000
Quarters > 0 > income Statement > eps
-1.6159737983688223
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
108839636
Quarters > 0 > income Statement > income Tax Expense
-1628000
Quarters > 0 > income Statement > EBITDA
-165841000
Quarters > 0 > income Statement > operating Margin
-1275.303098338572
Quarters > 0 > income Statement > total Other Income Expense Net
-120708000
Quarters > 0 > balance Sheet > cash
122076000
Quarters > 0 > balance Sheet > short Term Investments
24578000
Quarters > 0 > balance Sheet > receivables
22792000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
172374000
Quarters > 0 > balance Sheet > property Plant Equipment
3985000
Quarters > 0 > balance Sheet > total Assets
178518000
Quarters > 0 > balance Sheet > payables
34703000
Quarters > 0 > balance Sheet > short Term Debt
5533000
Quarters > 0 > balance Sheet > long Term Debt
51599000
Quarters > 0 > balance Sheet > total Liabilities
187866000
Quarters > 0 > balance Sheet > equity
-9346000
Quarters > 0 > cash Flow > net Income
-175882000
Quarters > 0 > cash Flow > depreciation
1704000
Quarters > 0 > cash Flow > change In Working Capital
-1645000
Quarters > 0 > cash Flow > cash From Operations
-53893000
Quarters > 0 > cash Flow > capital Expenditures
57000
Quarters > 0 > cash Flow > cash From Investing
-24799000
Quarters > 0 > cash Flow > cash From Financing
104949000
Quarters > 0 > cash Flow > net Change In Cash
25512000
Quarters > 0 > ratios > PE
-1.6159737983688223
Quarters > 0 > ratios > PB
-51.9393084271346
Quarters > 0 > ratios > ROE
1881.8959982880376
Quarters > 0 > ratios > ROA
-98.52339820074167
Quarters > 0 > ratios > FCF
-53950000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-12.112707678491244
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
6464000
Quarters > 1 > income Statement > cost Of Revenue
-526000
Quarters > 1 > income Statement > gross Profit
6990000
Quarters > 1 > income Statement > operating Expenses
52299000
Quarters > 1 > income Statement > operating Income
-45309000
Quarters > 1 > income Statement > interest Expense
12178000
Quarters > 1 > income Statement > pretax Income
-134991000
Quarters > 1 > income Statement > net Income
-135183000
Quarters > 1 > income Statement > eps
-2.6005686227370646
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
51982093
Quarters > 1 > income Statement > income Tax Expense
194000
Quarters > 1 > income Statement > EBITDA
-114707000
Quarters > 1 > income Statement > operating Margin
-700.9436881188119
Quarters > 1 > income Statement > total Other Income Expense Net
-89682000
Quarters > 1 > balance Sheet > cash
96563000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
12157000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
111511000
Quarters > 1 > balance Sheet > property Plant Equipment
5005000
Quarters > 1 > balance Sheet > total Assets
118967000
Quarters > 1 > balance Sheet > payables
32862000
Quarters > 1 > balance Sheet > short Term Debt
5868000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
225613000
Quarters > 1 > balance Sheet > equity
-106646000
Quarters > 1 > cash Flow > net Income
-135183000
Quarters > 1 > cash Flow > depreciation
5198000
Quarters > 1 > cash Flow > change In Working Capital
1679000
Quarters > 1 > cash Flow > cash From Operations
-37586000
Quarters > 1 > cash Flow > capital Expenditures
78000
Quarters > 1 > cash Flow > cash From Investing
-167000
Quarters > 1 > cash Flow > cash From Financing
123024000
Quarters > 1 > cash Flow > net Change In Cash
96564000
Quarters > 1 > ratios > PE
-2.6005686227370646
Quarters > 1 > ratios > PB
-2.1739224610393264
Quarters > 1 > ratios > ROE
126.7586219830092
Quarters > 1 > ratios > ROA
-113.6306706901914
Quarters > 1 > ratios > FCF
-37664000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-5.826732673267327
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
2734000
Quarters > 2 > income Statement > cost Of Revenue
526000
Quarters > 2 > income Statement > gross Profit
2208000
Quarters > 2 > income Statement > operating Expenses
54457000
Quarters > 2 > income Statement > operating Income
-52249000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-48910000
Quarters > 2 > income Statement > net Income
-49029000
Quarters > 2 > income Statement > eps
-0.9431901866667816
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
51982093
Quarters > 2 > income Statement > income Tax Expense
119000
Quarters > 2 > income Statement > EBITDA
-51818000
Quarters > 2 > income Statement > operating Margin
-1911.0826627651793
Quarters > 2 > income Statement > total Other Income Expense Net
3339000
Quarters > 2 > balance Sheet > cash
10436000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
809000
Quarters > 2 > balance Sheet > inventories
393000
Quarters > 2 > balance Sheet > total Current Assets
28608000
Quarters > 2 > balance Sheet > property Plant Equipment
7980000
Quarters > 2 > balance Sheet > total Assets
39426000
Quarters > 2 > balance Sheet > payables
36583000
Quarters > 2 > balance Sheet > short Term Debt
5726000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
118486000
Quarters > 2 > balance Sheet > equity
-79060000
Quarters > 2 > cash Flow > net Income
-49029000
Quarters > 2 > cash Flow > depreciation
431000
Quarters > 2 > cash Flow > change In Working Capital
4099000
Quarters > 2 > cash Flow > cash From Operations
-48342000
Quarters > 2 > cash Flow > capital Expenditures
255000
Quarters > 2 > cash Flow > cash From Investing
8912000
Quarters > 2 > cash Flow > cash From Financing
22568000
Quarters > 2 > cash Flow > net Change In Cash
10147000
Quarters > 2 > ratios > PE
-0.9431901866667816
Quarters > 2 > ratios > PB
-2.932458067037693
Quarters > 2 > ratios > ROE
62.01492537313433
Quarters > 2 > ratios > ROA
-124.35702328412724
Quarters > 2 > ratios > FCF
-48597000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-17.775054864667155
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
2734000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
2734000
Quarters > 3 > income Statement > operating Expenses
54983000
Quarters > 3 > income Statement > operating Income
-52249000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-48910000
Quarters > 3 > income Statement > net Income
-49029000
Quarters > 3 > income Statement > eps
-0.9431901866667816
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
51982093
Quarters > 3 > income Statement > income Tax Expense
119000
Quarters > 3 > income Statement > EBITDA
-51818000
Quarters > 3 > income Statement > operating Margin
-1911.0826627651793
Quarters > 3 > income Statement > total Other Income Expense Net
3339000
Quarters > 3 > balance Sheet > cash
10147000
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
809000
Quarters > 3 > balance Sheet > inventories
393000
Quarters > 3 > balance Sheet > total Current Assets
28608000
Quarters > 3 > balance Sheet > property Plant Equipment
7980000
Quarters > 3 > balance Sheet > total Assets
39426000
Quarters > 3 > balance Sheet > payables
36583000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
43539000
Quarters > 3 > balance Sheet > total Liabilities
118485000
Quarters > 3 > balance Sheet > equity
-79059000
Quarters > 3 > cash Flow > net Income
-49029000
Quarters > 3 > cash Flow > depreciation
431000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > ratios > PE
-0.9431901866667816
Quarters > 3 > ratios > PB
-2.9324951590584245
Quarters > 3 > ratios > ROE
62.01570978636208
Quarters > 3 > ratios > ROA
-124.35702328412724
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
9198000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
9198000
Annuals > 0 > income Statement > operating Expenses
106756000
Annuals > 0 > income Statement > operating Income
-97558000
Annuals > 0 > income Statement > interest Expense
12178000
Annuals > 0 > income Statement > pretax Income
-183901000
Annuals > 0 > income Statement > net Income
-184212000
Annuals > 0 > income Statement > eps
-3.543758809403846
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
51982093
Annuals > 0 > income Statement > income Tax Expense
313000
Annuals > 0 > income Statement > EBITDA
-166525000
Annuals > 0 > income Statement > operating Margin
-1060.6436181778647
Annuals > 0 > income Statement > total Other Income Expense Net
-86343000
Annuals > 0 > balance Sheet > cash
96563000
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
12157000
Annuals > 0 > balance Sheet > inventories
0
Annuals > 0 > balance Sheet > total Current Assets
111511000
Annuals > 0 > balance Sheet > property Plant Equipment
5005000
Annuals > 0 > balance Sheet > total Assets
118967000
Annuals > 0 > balance Sheet > payables
32862000
Annuals > 0 > balance Sheet > short Term Debt
5868000
Annuals > 0 > balance Sheet > long Term Debt
46326000
Annuals > 0 > balance Sheet > total Liabilities
225613000
Annuals > 0 > balance Sheet > equity
-106646000
Annuals > 0 > cash Flow > net Income
-184212000
Annuals > 0 > cash Flow > depreciation
5198000
Annuals > 0 > cash Flow > change In Working Capital
1679000
Annuals > 0 > cash Flow > cash From Operations
-85928000
Annuals > 0 > cash Flow > capital Expenditures
333000
Annuals > 0 > cash Flow > cash From Investing
8745000
Annuals > 0 > cash Flow > cash From Financing
145592000
Annuals > 0 > cash Flow > net Change In Cash
69646000
Annuals > 0 > ratios > PE
-3.543758809403846
Annuals > 0 > ratios > PB
-2.071562883277385
Annuals > 0 > ratios > ROE
172.732216867018
Annuals > 0 > ratios > ROA
-154.84293963872335
Annuals > 0 > ratios > FCF
-86261000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-9.378234398782343
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
17477000
Annuals > 1 > income Statement > cost Of Revenue
-23000
Annuals > 1 > income Statement > gross Profit
17500000
Annuals > 1 > income Statement > operating Expenses
120186000
Annuals > 1 > income Statement > operating Income
-102709000
Annuals > 1 > income Statement > interest Expense
5178000
Annuals > 1 > income Statement > pretax Income
-109819000
Annuals > 1 > income Statement > net Income
-110426000
Annuals > 1 > income Statement > eps
-2.434875846931673
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
45351799
Annuals > 1 > income Statement > income Tax Expense
607000
Annuals > 1 > income Statement > EBITDA
-102041000
Annuals > 1 > income Statement > operating Margin
-587.6809521084854
Annuals > 1 > income Statement > total Other Income Expense Net
-7110000
Annuals > 1 > balance Sheet > cash
26918000
Annuals > 1 > balance Sheet > short Term Investments
70000
Annuals > 1 > balance Sheet > receivables
15707000
Annuals > 1 > balance Sheet > inventories
417000
Annuals > 1 > balance Sheet > total Current Assets
48189000
Annuals > 1 > balance Sheet > property Plant Equipment
9127000
Annuals > 1 > balance Sheet > total Assets
69561000
Annuals > 1 > balance Sheet > payables
37679000
Annuals > 1 > balance Sheet > short Term Debt
5308000
Annuals > 1 > balance Sheet > long Term Debt
27914000
Annuals > 1 > balance Sheet > total Liabilities
101593000
Annuals > 1 > balance Sheet > equity
-32032000
Annuals > 1 > cash Flow > net Income
-110426000
Annuals > 1 > cash Flow > depreciation
2599000
Annuals > 1 > cash Flow > change In Working Capital
17307000
Annuals > 1 > cash Flow > cash From Operations
-81614000
Annuals > 1 > cash Flow > capital Expenditures
540000
Annuals > 1 > cash Flow > cash From Investing
-7731000
Annuals > 1 > cash Flow > cash From Financing
29081000
Annuals > 1 > cash Flow > net Change In Cash
-59818000
Annuals > 1 > ratios > PE
-2.434875846931673
Annuals > 1 > ratios > PB
-6.017268536151349
Annuals > 1 > ratios > ROE
344.7365134865135
Annuals > 1 > ratios > ROA
-158.74699903681662
Annuals > 1 > ratios > FCF
-82154000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-4.700692338502031
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
12179000
Annuals > 2 > income Statement > cost Of Revenue
995000
Annuals > 2 > income Statement > gross Profit
12179000
Annuals > 2 > income Statement > operating Expenses
69289000
Annuals > 2 > income Statement > operating Income
-57110000
Annuals > 2 > income Statement > interest Expense
707000
Annuals > 2 > income Statement > pretax Income
-54294000
Annuals > 2 > income Statement > net Income
-54274000
Annuals > 2 > income Statement > eps
-1.3093932670059243
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
41449732
Annuals > 2 > income Statement > income Tax Expense
-20000
Annuals > 2 > income Statement > EBITDA
-55412000
Annuals > 2 > income Statement > operating Margin
-468.9219147713277
Annuals > 2 > income Statement > total Other Income Expense Net
2816000
Annuals > 2 > balance Sheet > cash
86737000
Annuals > 2 > balance Sheet > short Term Investments
1048000
Annuals > 2 > balance Sheet > receivables
279000
Annuals > 2 > balance Sheet > inventories
373000
Annuals > 2 > balance Sheet > total Current Assets
106383000
Annuals > 2 > balance Sheet > property Plant Equipment
7386000
Annuals > 2 > balance Sheet > total Assets
116004000
Annuals > 2 > balance Sheet > payables
19359000
Annuals > 2 > balance Sheet > short Term Debt
5851000
Annuals > 2 > balance Sheet > long Term Debt
28663000
Annuals > 2 > balance Sheet > total Liabilities
70528000
Annuals > 2 > balance Sheet > equity
45476000
Annuals > 2 > cash Flow > net Income
-54274000
Annuals > 2 > cash Flow > depreciation
1698000
Annuals > 2 > cash Flow > change In Working Capital
5713000
Annuals > 2 > cash Flow > cash From Operations
-44928000
Annuals > 2 > cash Flow > capital Expenditures
561000
Annuals > 2 > cash Flow > cash From Investing
8868000
Annuals > 2 > cash Flow > cash From Financing
37268000
Annuals > 2 > cash Flow > net Change In Cash
183000
Annuals > 2 > ratios > PE
-1.3093932670059243
Annuals > 2 > ratios > PB
3.873721545430557
Annuals > 2 > ratios > ROE
-119.34646846688364
Annuals > 2 > ratios > ROA
-46.7863177131823
Annuals > 2 > ratios > FCF
-45489000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-3.7350357172181625
Annuals > 2 > health Score
19
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
4194000
Annuals > 3 > income Statement > cost Of Revenue
1017000
Annuals > 3 > income Statement > gross Profit
4194000
Annuals > 3 > income Statement > operating Expenses
56309000
Annuals > 3 > income Statement > operating Income
-52114000
Annuals > 3 > income Statement > interest Expense
138000
Annuals > 3 > income Statement > pretax Income
-49272000
Annuals > 3 > income Statement > net Income
-49636000
Annuals > 3 > income Statement > eps
-1.2672540690712188
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
39168152
Annuals > 3 > income Statement > income Tax Expense
364000
Annuals > 3 > income Statement > EBITDA
-52762000
Annuals > 3 > income Statement > operating Margin
-1242.5846447305676
Annuals > 3 > income Statement > total Other Income Expense Net
2843000
Annuals > 3 > balance Sheet > cash
86553000
Annuals > 3 > balance Sheet > short Term Investments
8829000
Annuals > 3 > balance Sheet > receivables
11587000
Annuals > 3 > balance Sheet > inventories
392000
Annuals > 3 > balance Sheet > total Current Assets
115578000
Annuals > 3 > balance Sheet > property Plant Equipment
3198000
Annuals > 3 > balance Sheet > total Assets
121985000
Annuals > 3 > balance Sheet > payables
14602000
Annuals > 3 > balance Sheet > short Term Debt
1282000
Annuals > 3 > balance Sheet > long Term Debt
8745000
Annuals > 3 > balance Sheet > total Liabilities
33118000
Annuals > 3 > balance Sheet > equity
88867000
Annuals > 3 > cash Flow > net Income
-49635000
Annuals > 3 > cash Flow > depreciation
-1288000
Annuals > 3 > cash Flow > change In Working Capital
979000
Annuals > 3 > cash Flow > cash From Operations
-47629000
Annuals > 3 > cash Flow > capital Expenditures
534000
Annuals > 3 > cash Flow > cash From Investing
-1793000
Annuals > 3 > cash Flow > cash From Financing
25447000
Annuals > 3 > cash Flow > net Change In Cash
-19134000
Annuals > 3 > ratios > PE
-1.2672540690712188
Annuals > 3 > ratios > PB
1.8731885401780186
Annuals > 3 > ratios > ROE
-55.854254110074606
Annuals > 3 > ratios > ROA
-40.6902488010821
Annuals > 3 > ratios > FCF
-48163000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-11.483786361468765
Annuals > 3 > health Score
34
Valuation > metrics > PE
-1.6159737983688223
Valuation > metrics > PB
-51.9393084271346
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
1881.8959982880376
Profitability > metrics > ROA
-102.03510970331952
Profitability > metrics > Net Margin
-39.48854961832061
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-5.8288353001539255
Risk > final Score
7
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.284073963614674
Liquidity > metrics > Quick Ratio
4.284073963614674
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
15
Prev Risks > 1
-42
Prev Risks > 2
-42
Prev Liquidities > 0
100
Prev Liquidities > 1
43
Prev Liquidities > 2
49
Updated At
2025-12-14T00:41:52.328Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-21
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.29
Earnings History > 0 > eps Difference
0.29
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-29
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
-0.6048
Earnings History > 1 > eps Difference
0.6048
Earnings History > 1 > surprise Percent
100
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-15
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-2
Earnings History > 2 > eps Estimate
-0.43
Earnings History > 2 > eps Difference
-1.57
Earnings History > 2 > surprise Percent
-365.1163
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1.82
Earnings History > 3 > eps Estimate
-0.43
Earnings History > 3 > eps Difference
-1.39
Earnings History > 3 > surprise Percent
-323.2558
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-21
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.76
Earnings History > 4 > eps Estimate
-0.56
Earnings History > 4 > eps Difference
-0.2
Earnings History > 4 > surprise Percent
-35.7143
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-09-25
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.8716
Earnings History > 5 > eps Estimate
-0.6328
Earnings History > 5 > eps Difference
-0.2388
Earnings History > 5 > surprise Percent
-37.737
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-21
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.48
Earnings History > 6 > eps Estimate
-0.47
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-2.1277
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-27
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.6412
Earnings History > 7 > eps Estimate
-0.4
Earnings History > 7 > eps Difference
-0.2412
Earnings History > 7 > surprise Percent
-60.3
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-21
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.98
Earnings History > 8 > eps Estimate
-0.98
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-09-28
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.39
Earnings History > 9 > eps Estimate
-1.39
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-16
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.29
Earnings History > 10 > eps Estimate
-0.29
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-29
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.2758
Earnings History > 11 > eps Estimate
0.08
Earnings History > 11 > eps Difference
-0.3558
Earnings History > 11 > surprise Percent
-444.75
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-09-22
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-07
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-1.27
Earnings History > 15 > eps Estimate
-0.88
Earnings History > 15 > eps Difference
-0.39
Earnings History > 15 > surprise Percent
-44.3182
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
-0.3559
Earnings History > 16 > eps Difference
0.3559
Earnings History > 16 > surprise Percent
100
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-09-20
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
-0.821
Earnings History > 17 > eps Difference
0.821
Earnings History > 17 > surprise Percent
100
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-12
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.4384
Earnings History > 18 > eps Estimate
-0.3313
Earnings History > 18 > eps Difference
-0.1071
Earnings History > 18 > surprise Percent
-32.3272
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-04
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.4786
Earnings History > 19 > eps Estimate
-0.4786
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
0
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-12
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.3927
Earnings History > 20 > eps Estimate
-0.3778
Earnings History > 20 > eps Difference
-0.0149
Earnings History > 20 > surprise Percent
-3.9439
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-16
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.3542
Earnings History > 21 > eps Estimate
-0.62
Earnings History > 21 > eps Difference
0.2658
Earnings History > 21 > surprise Percent
42.871
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-14
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.27
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.27
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-03-31
Earnings History > 23 > report Date
2019-05-15
Earnings History > 23 > date
2019-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
0
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AInventiva drops 35% in a month after InvestingPro’s overvalued warning By Investing.com Investing.com Australia
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
STRONG BUY
Target Price:
$15.875
Analyst Picks
Strong Buy
6
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 3.55% of the total shares of Inventiva Sa
1.
Yiheng Capital LLC(1.902%)
since
2025/06/30
2.
NEA Management Company, LLC(1.0518%)
since
2025/06/30
3.
Bvf Inc(0.4933%)
since
2025/06/30
4.
Commonwealth Equity Services Inc(0.0391%)
since
2025/06/30
5.
UBS Group AG(0.0197%)
since
2025/06/30
6.
Citadel Advisors Llc(0.0168%)
since
2025/06/30
7.
Wealth Enhancement Advisory Services, LLC(0.0119%)
since
2025/06/30
8.
Creative Planning Inc(0.0072%)
since
2025/06/30
9.
Fidelity Nasdaq Composite Index(0.0034%)
since
2025/07/31
10.
Morgan Stanley - Brokerage Accounts(0.0015%)
since
2025/06/30
11.
Covestor Ltd(0.0003%)
since
2025/06/30
12.
Atlantic Union Bankshares Corp(0.0002%)
since
2025/06/30
13.
BNP Paribas Arbitrage, SA(0.0001%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
-0.29
EPS Difference
0.29
Surprise Percent
100%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.